- Home
- ROL vs BNTX Comparison
ROL vs BNTX Comparison
Compare ROL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROL
- BNTX
- Stock Information
- Founded
- ROL 1948
- BNTX 2008
- Country
- ROL United States
- BNTX Germany
- Employees
- ROL N/A
- BNTX N/A
- Industry
- ROL Diversified Commercial Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ROL Finance
- BNTX Health Care
- Exchange
- ROL Nasdaq
- BNTX Nasdaq
- Market Cap
- ROL 23.9B
- BNTX 23.9B
- IPO Year
- ROL N/A
- BNTX 2019
- Fundamental
- Price
- ROL $46.55
- BNTX $115.21
- Analyst Decision
- ROL Buy
- BNTX Strong Buy
- Analyst Count
- ROL 6
- BNTX 15
- Target Price
- ROL $51.00
- BNTX $143.50
- AVG Volume (30 Days)
- ROL 1.7M
- BNTX 659.5K
- Earning Date
- ROL 02-12-2025
- BNTX 11-04-2024
- Dividend Yield
- ROL 1.42%
- BNTX N/A
- EPS Growth
- ROL 16.84
- BNTX N/A
- EPS
- ROL 0.97
- BNTX N/A
- Revenue
- ROL $3,310,625,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- ROL $10.99
- BNTX N/A
- Revenue Next Year
- ROL $8.38
- BNTX N/A
- P/E Ratio
- ROL $48.05
- BNTX N/A
- Revenue Growth
- ROL 11.07
- BNTX N/A
- 52 Week Low
- ROL $40.41
- BNTX $76.53
- 52 Week High
- ROL $52.16
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ROL 29.68
- BNTX 48.71
- Support Level
- ROL $46.18
- BNTX $109.52
- Resistance Level
- ROL $46.68
- BNTX $115.34
- Average True Range (ATR)
- ROL 0.75
- BNTX 4.24
- MACD
- ROL -0.27
- BNTX -0.72
- Stochastic Oscillator
- ROL 11.02
- BNTX 27.24
About ROL Rollins Inc.
Rollins is a global leader in route-based pest-control services, with operations spanning North, Central and South America, Europe, the Middle East and Africa and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, market leader in the US, where it boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on US and Canadian markets.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.